MINNEAPOLIS, Nov. 30 /PRNewswire/ -- Nonin Medical, Inc., a leading innovator of
physiological monitoring solutions and the inventor of fingertip pulse oximetry,
was awarded Frost and Sullivan's 2009 North American Product Line Strategy Award
in Remote Patient Monitoring. Recognized for providing secure, accurate remote
physiological monitoring, Nonin Medical was acknowledged for its leadership as a
premier provider of telemedicine monitoring equipment.



The Product Line Strategy award is chosen by Frost and Sullivan's analyst team,
which conducts interviews with suppliers, end-users and industry experts to
determine the product that best addresses market needs and dynamics. "As the
world of telemedicine continues to evolve, there is a need for monitoring
companies to develop new monitoring devices in order to perform that critical
first step of any telemedicine system, vital sign or data acquisition," observed
industry analyst Zachary Bujnoch. "Nonin Medical has already established itself
as a true thought leader in this monitoring specific side of remote medicine."



With rising healthcare costs driving care into the home, Nonin's vision of
remote monitoring has focused on how to provide cost-effective, accurate
physiological data exchange with no proprietary boundaries. Nonin's choice to
promote secure information exchange and interoperability has enabled a simpler
delivery of health care for telemedicine systems, healthcare systems, systems
integrator partners and patients worldwide. Nonin's remote monitoring solutions
have provided patients with better information about their health status and
allowed clinicians to monitor vital signs with greater ease across the globe.



Together with other industry leaders within the Continua Health Alliance, Nonin
is contributing to the advancement of interoperable devices and open standards
development to promote the Personal Health ecosystem. "Through these
partnerships, our goal for interoperable remote monitoring is to simplify the
delivery of health care with an end result that will ultimately benefit both the
patient and provider with reduced costs, added security, improved efficiencies
and increased compliance rates," said Jayant Parthasarathy, Ph.D., eHealth
Business Manager at Nonin Medical and Chairperson of the Continua Health
Alliance Technical Working Group.



Known for its accurate PureSAT® pulse oximetry technology, innovative design,
low power consumption and unmatched durability, Nonin's vital sign monitoring
solutions have become the gold standard for assessment of a wide range of
chronic disease conditions, such as COPD, CHF and asthma.



About Nonin Medical, Inc. - www.nonin.com

Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing
in the design and manufacturing of noninvasive physiological monitoring
solutions. Nonin distributes its products to health professionals in more than
125 countries and has over 100+ OEM partners worldwide. With over 20 years of
industry-leading capabilities in signal processing and sensor design expertise,
Nonin's innovative noninvasive physiological technologies enable clinicians to
accurately monitor a patient's true condition in the most challenging
environments.



About Frost & Sullivan -www.frost.com

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate
growth and achieve best in class positions in growth, innovation and leadership.
The company's Growth Partnership Service provides the CEO and the CEO's Growth
Team with disciplined research and best practice models to drive the generation,
evaluation, and implementation of powerful growth strategies. Frost & Sullivan
leverages over 45 years of experience in partnering with Global 1000 companies,
emerging businesses and the investment community from more than 35 offices on
six continents. To join our Growth Partnership, please visit
http://www.frost.com.




SOURCE Nonin Medical, Inc.